Literature DB >> 26055747

Influenza A and Parvovirus B19 Seropositivity Rates in Gabonese Infants.

Julian J Gabor1, Norbert G Schwarz1, Meral Esen1, Peter G Kremsner1, Martin P Grobusch2.   

Abstract

Clinical and epidemiological data from Central Africa on influenza A and parvovirus B19 infections are limited. We analyzed 162 blood samples of infants 3, 9, 15, and 30 months of age for IgG antibodies against both pathogens. Antibody responses were 0, 3.7%, 12.3%, and 20.4% against influenza A; and 1.2%, 2.5%, 3.1%, and 9.3% against parvovirus B19, respectively. Seropositivity rates were 89.5 (95% confidence interval [CI]: 59-120.1) and 38.2 (95% CI: 18.9-57.6)/1,000 person-years at risk for influenza A and parvovirus B19, respectively. Our data add to the understanding of the epidemiology of both conditions. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26055747      PMCID： PMC4530772          DOI： 10.4269/ajtmh.14-0558

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  15 in total

Review 1.  Incidence of influenza and associated illness in children aged 0-19 years: a systematic review.

Authors:  Herman J Bueving; Johannes C van der Wouden; Marjolein Y Berger; Siep Thomas
Journal:  Rev Med Virol       Date:  2005 Nov-Dec       Impact factor: 6.989

2.  Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection.

Authors:  J L Abkowitz; K E Brown; R W Wood; N L Kovach; S W Green; N S Young
Journal:  J Infect Dis       Date:  1997-07       Impact factor: 5.226

3.  Cellular and humoral responses to influenza in gabonese children living in rural and semi-urban areas.

Authors:  E van Riet; A A Adegnika; K Retra; R Vieira; A G M Tielens; B Lell; S Issifou; F C Hartgers; G F Rimmelzwaan; P G Kremsner; M Yazdanbakhsh
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

4.  Circulation of human influenza viruses and emergence of Oseltamivir-resistant A(H1N1) viruses in Cameroon, Central Africa.

Authors:  Richard Njouom; Serge A Sadeuh Mba; Dominique Noah Noah; Victoria Gregory; Patrick Collins; Pierre Cappy; Alan Hay; Dominique Rousset
Journal:  BMC Infect Dis       Date:  2010-03-08       Impact factor: 3.090

5.  Parvovirus B19 infection contributes to severe anemia in young children in Papua New Guinea.

Authors:  James Wildig; Pascal Michon; Peter Siba; Mata Mellombo; Alice Ura; Ivo Mueller; Yvonne Cossart
Journal:  J Infect Dis       Date:  2006-06-14       Impact factor: 5.226

6.  Widespread infection with homologues of human parvoviruses B19, PARV4, and human bocavirus of chimpanzees and gorillas in the wild.

Authors:  Colin P Sharp; Matthew LeBreton; Kalle Kantola; Ahmadou Nana; Joseph Le Doux Diffo; Cyrille F Djoko; Ubald Tamoufe; John A Kiyang; Tafon G Babila; Eitel Mpoudi Ngole; Oliver G Pybus; Eric Delwart; Eric Delaporte; Martine Peeters; Maria Soderlund-Venermo; Klaus Hedman; Nathan D Wolfe; Peter Simmonds
Journal:  J Virol       Date:  2010-07-28       Impact factor: 5.103

7.  Intermittent preventive treatment against malaria in infants in Gabon--a randomized, double-blind, placebo-controlled trial.

Authors:  Martin P Grobusch; Bertrand Lell; Norbert G Schwarz; Julian Gabor; Jenny Dornemann; Marc Potschke; Sunny Oyakhirome; Georg C Kiessling; Magdalena Necek; Matthias U Langin; Peter Klein Klouwenberg; Anna Klopfer; Benjamin Naumann; Handan Altun; Selidji T Agnandji; Julia Goesch; Marieluise Decker; Carmen L Ospina Salazar; Christian Supan; Davy U Kombila; Lea Borchert; Kai B Koster; Peter Pongratz; Akim A Adegnika; Isabelle von Glasenapp; Saadou Issifou; Peter G Kremsner
Journal:  J Infect Dis       Date:  2007-10-25       Impact factor: 5.226

Review 8.  Human parvovirus B19.

Authors:  Erik D Heegaard; Kevin E Brown
Journal:  Clin Microbiol Rev       Date:  2002-07       Impact factor: 26.132

9.  No rebound of morbidity following intermittent preventive sulfadoxine-pyrimethamine treatment of malaria in infants in Gabon.

Authors:  Martin P Grobusch; Julian J Gabor; John J Aponte; Norbert G Schwarz; Marc Poetschke; Jenny Doernemann; Katharina Schuster; Kai B Koester; Katharina Profanter; Lea B Borchert; Florian Kurth; Peter Pongratz; Saadou Issifou; Bertrand Lell; Peter G Kremsner
Journal:  J Infect Dis       Date:  2009-12-01       Impact factor: 5.226

10.  Changing epidemiology of human parvovirus 4 infection in sub-Saharan Africa.

Authors:  Colin P Sharp; Marion Vermeulen; Yacouba Nébié; Cyrille F Djoko; Matthew LeBreton; Ubald Tamoufe; Anne W Rimoin; Patrick K Kayembe; Jean K Carr; Annabelle Servant-Delmas; Syria Laperche; G L Abby Harrison; Oliver G Pybus; Eric Delwart; Nathan D Wolfe; Andrew Saville; Jean Jacques Lefrère; Peter Simmonds
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883
View more
  2 in total

1.  Detection of human parvovirus B19 in serum samples from children under 5 years of age with rash-fever illnesses in the Democratic Republic of the Congo.

Authors:  Tony Bokalanga Wawina; Olivier Mbaya Tshiani; Steve Mundeke Ahuka; Elisabeth Simbu Pukuta; Michel Ntetani Aloni; Christopher Jacob Kasanga; Jean-Jacques Tamfum Muyembe
Journal:  Int J Infect Dis       Date:  2017-09-22       Impact factor: 3.623

2.  The epidemiology of seasonal influenza after the 2009 influenza pandemic in Africa: a systematic review.

Authors:  Adamou Lagare; Soatiana Rajatonirina; Jean Testa; Saidou Mamadou
Journal:  Afr Health Sci       Date:  2020-12       Impact factor: 0.927
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.